Clover Health Investments Corp (NAS:CLOV)
$ 3.26 -0.05 (-1.51%) Market Cap: 1.63 Bil Enterprise Value: 1.33 Bil PE Ratio: 0 PB Ratio: 4.77 GF Score: 35/100

Clover Health Investments Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2021 / 04:20PM GMT
Release Date Price: $7.18 (-4.65%)
Jonathan Yong;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Good morning and thank you for joining us here at the Credit Suisse Healthcare Conference. I'm Jonathan Yong and will be moderating today's fireside chat. Today, we are pleased to have Clover Health, a tech-enabled health insurer, focused on Medicare Advantage and direct contracting markets. From the company, we have Vivek Garipalli, Founder, Chairman and CEO of Clover; Andrew Toy, President and Chief Technology Officer; and Derrick Nueman, VP of Investor Relations and Corporate Strategy.

So the format of this will be a fireside chat, and you can e-mail me questions at [email protected], which should also be on your screen as well.

So with that, welcome Vivek, Andrew and Derrick.

Questions & Answers

Jonathan Yong;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

So just to get started, you guys recently reported your third quarter. So why don't you provide a quick recap and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot